Literature DB >> 34381254

Compatibility of Lactated Ringer's Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.

Margaux Vallée1, Isabelle Barthélémy2, Mihaela Friciu3, Élaine Pelletier4, Jean-Marc Forest4, France Benoit5, Grégoire Leclair3.   

Abstract

Objective: To test the compatibility of intravenous (IV) lactated Ringer's injection (LR) with 94 injectable (IV) drugs during simulated Y-site administration.
Methods: Ninety-four IV drugs were investigated for compatibility with LR (Baxter). Each sample was prepared in duplicate and performed at room temperature. Two observers performed visual evaluation independently immediately upon mixing and then 15 minutes, 1 hour, 2 hours, 3 hours, and 4 hours after admixture. Another observer performed a particle counting test on 1 of the 2 duplicates of each admixture that did not immediately show incompatibility and then after 4 hours by a light obscuration particle count test.
Results: Of the 94 tested drugs, 86 were found to be compatible with LR. A total of 8 drugs were found to be physically incompatible. Of these incompatible drugs, 7 were directly identified visually and 1 was confirmed by the light obscuration particle count test.
Conclusion: Lactated Ringer's injection was physically compatible for 4 hours with 86 tested drugs during simulated Y-site administration. Eight drugs, ciprofloxacin, cyclosporine, diazepam, ketamine, lorazepam, nitroglycerin, phenytoin, and propofol, were found to be incompatible and should not be administered with LR.
© The Author(s) 2019.

Entities:  

Keywords:  Y-injection site; compatibility; lactated Ringer’s injection

Year:  2019        PMID: 34381254      PMCID: PMC8326865          DOI: 10.1177/0018578719888913

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  2 in total

1.  Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets.

Authors:  L V Allen; R S Levinson; D Phisutsinthop
Journal:  Am J Hosp Pharm       Date:  1977-09

2.  Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration.

Authors:  Thomas Sullivan; Jean-Marc Forest; Grégoire Leclair
Journal:  Hosp Pharm       Date:  2015-03
  2 in total
  1 in total

Review 1.  Crystalloid and Colloid Compositions and Their Impact.

Authors:  Elke Rudloff; Kate Hopper
Journal:  Front Vet Sci       Date:  2021-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.